Utilities Registry – Page 3 – Center for Health Decision Science

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Valuation

Population

Condition

Viewing 21 - 30 of 44 results

Title	Year(s) of data collection	Valuation Method	Country	Condition
Selection of mental health health state utilities (Shoji M et al., BMC Psychiatry. 2023. doi:10.1186/s12888-023-04602-5)	2019 - 2020	EQ-5D-5L	Japan	Depression
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 31 participants in a non-randomized controlled, interventional study investigating effects of community pharmacists' cognitive behavioral therapy based interventions on medication adherence and relevant indicators in patients with depression
Title Selection of mental health health state utilities (Adu MK et al., Brain Sci. 2023. doi:10.3390/brainsci13020293)	Year(s) of data collection 2020 - 2022	Valuation Method EQ-5D-5L	Country Canada	Condition Depression
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 78 participants in the patient-centered randomized controlled pilot trial investigating combining repetitive transcranial magnetic stimulation with internet-delivered cognitive behavior therapy for the treatment of resistant depression
Title Selection of mental health health state utilities (Stolz M et al., Eur J Health Econ. 2022. doi:10.1007/s10198-022-01543-w)	Year(s) of data collection 2008 - 2013	Valuation Method EQ-5D-3L, SF-6D	Country Germany	Condition Depression
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 566 cardiac patients with depressive symptoms as part of the SPIRRCAD (Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease) trial
Title Selection of mental health health state utilities (Leijdesdorff SMJ et al., J Ment Health. 2023. doi:10.1080/09638237.2020.1836555)	Year(s) of data collection 2018 - 2019	Valuation Method EQ-5D-5L	Country Netherlands	Condition Mental Health
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 80 visitors of a Dutch multicenter organization for mental health support
Title Selection of mental health health state utilities (Jain S et al., BMC Psychiatry. 2022. doi:10.1186/s12888-022-04165-x)	Year(s) of data collection 2017	Valuation Method EQ-5D, SF-6D	Country United States of America	Condition Depression
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 39331 participants in the 2017 US National Health and Wellness Survey
Title Selection of mental health health state utilities (Denee T et al., J Affect Disord. 2023. doi:10.1016/j.jad.2022.12.135)	Year(s) of data collection 2019	Valuation Method EQ-5D-5L	Country United Kingdom of Great Britain and Northern Ireland	Condition Depression - caregivers
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 99 carers of individuals with symptomatic treatment-resistant depression or in remission post-TRD
Title Selection of neurological disease health state utilities (Kalra S et al., Cureus. 2023. doi:10.7759/cureus.35045)	Year(s) of data collection 2017 - 2020	Valuation Method EQ-5D-3L	Country India	Condition Epilepsy
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics 173 participants in a cohort study from a community-based randomized controlled trial to compare the QOL between people with epilepsy receiving home-based care (HBC) and routine clinic-based care (CBC)
Title Selection of neurological disease health state utilities (Janssen N et al., J Alzheimers Dis. 2022. doi:10.3233/JAD-215304)	Year(s) of data collection 2009 - 2011	Valuation Method SF-6D	Country Finland	Condition Cognitive decline
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics 1120 participants with longitudinal 2-year data from the FINGER study to investigate the association between cognition, health related quality of life, and costs in a population at risk for cognitive decline
Title Selection of neurological disease health state utilities (Gebrehiwet P et al., J Med Econ. 2023. doi:10.1080/13696998.2023.2192588)	Year(s) of data collection 2017 - 2019	Valuation Method EQ-5D-5L	Country Australia, Canada, Ireland, Netherlands, Spain, United States of America	Condition Amyotrophic lateral sclerosis
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics 456 participants with clinical trial data from FORTITUDE-ALS that evaluated reldesemtiv versus placebo in patients with ALS
Title Selection of neurological disease health state utilities (Looby A et al., J Med Econ. 2023. doi:10.1080/13696998.2023.2189395)	Year(s) of data collection 2022	Valuation Method EQ-5D-5L	Country United Kingdom of Great Britain and Northern Ireland	Condition Spinal cord injury
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics A cohort of 57 patients with spinal cord injury

← Previous results Next results →